Total Payments
$3,539
2024 Payments
$66.75
Companies
32
Transactions
171
Medicare Patients
2,389
Medicare Billing
$93,125
Payment Breakdown by Category
Food & Beverage$3,396 (96.0%)
Education$142.94 (4.0%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,396 | 168 | 96.0% |
| Education | $142.94 | 3 | 4.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $809.80 | 44 | $0 (2022) |
| GlaxoSmithKline, LLC. | $326.26 | 19 | $0 (2022) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $282.24 | 10 | $0 (2023) |
| ABBVIE INC. | $270.02 | 13 | $0 (2024) |
| Lilly USA, LLC | $234.72 | 8 | $0 (2022) |
| Astellas Pharma US Inc | $170.77 | 6 | $0 (2023) |
| Janssen Pharmaceuticals, Inc | $157.13 | 2 | $0 (2022) |
| AstraZeneca Pharmaceuticals LP | $153.34 | 11 | $0 (2022) |
| Novartis Pharmaceuticals Corporation | $146.76 | 7 | $0 (2022) |
| PFIZER INC. | $144.70 | 9 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $66.75 | 2 | ABBVIE INC. ($66.75) |
| 2023 | $333.05 | 10 | Astellas Pharma US Inc ($93.52) |
| 2022 | $797.84 | 18 | Lilly USA, LLC ($134.04) |
| 2021 | $422.86 | 19 | Novo Nordisk Inc ($74.47) |
| 2020 | $256.93 | 15 | Novo Nordisk Inc ($42.88) |
| 2019 | $285.52 | 19 | Sunovion Pharmaceuticals Inc. ($43.19) |
| 2018 | $724.48 | 48 | Novo Nordisk Inc ($296.57) |
| 2017 | $651.69 | 40 | Novo Nordisk Inc ($259.33) |
All Payment Transactions
171 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 06/26/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $47.32 | General |
| Category: FACIAL AESTHETICS | ||||||
| 06/26/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $19.43 | General |
| Category: FACIAL AESTHETICS | ||||||
| 09/08/2023 | Nevro Corp. | Senza (Device) | Food and Beverage | In-kind items and services | $33.72 | General |
| Category: Spinal Cord Stimulator | ||||||
| 04/10/2023 | Astellas Pharma US Inc | — | Education | In-kind items and services | $72.99 | General |
| 03/27/2023 | Astellas Pharma US Inc | Myrbetriq (Drug) | Food and Beverage | In-kind items and services | $20.53 | General |
| Category: Urology | ||||||
| 03/20/2023 | Neurocrine Biosciences, Inc. | — | Food and Beverage | In-kind items and services | $84.39 | General |
| 03/20/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.10 | General |
| Category: NEUROSCIENCE | ||||||
| 03/10/2023 | Nevro Corp. | Senza (Device) | Food and Beverage | In-kind items and services | $28.19 | General |
| Category: Spinal Cord Stimulator | ||||||
| 02/21/2023 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $16.50 | General |
| Category: NEUROSCIENCE | ||||||
| 02/10/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $23.97 | General |
| Category: NEUROSCIENCE | ||||||
| 01/30/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $22.38 | General |
| Category: DIABETES | ||||||
| 01/23/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $16.28 | General |
| Category: NEUROSCIENCE | ||||||
| 12/12/2022 | SI-BONE, Inc. | — | Food and Beverage | Cash or cash equivalent | $31.85 | General |
| 11/08/2022 | PFIZER INC. | PREVNAR 13 (Biological), PREVNAR 20, COMIRNATY | Food and Beverage | In-kind items and services | $16.09 | General |
| Category: VACCINES | ||||||
| 11/03/2022 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.70 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/11/2022 | PFIZER INC. | PREVNAR 13 (Biological), TRUMENBA, PREVNAR 20 | Food and Beverage | In-kind items and services | $15.19 | General |
| Category: VACCINES | ||||||
| 10/06/2022 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $124.98 | General |
| 10/03/2022 | Ultragenyx Pharmaceutical Inc. | Crysvita (Drug) | Food and Beverage | In-kind items and services | $27.23 | General |
| Category: XLH Metabolic Bone Disorder | ||||||
| 09/08/2022 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | Cash or cash equivalent | $124.99 | General |
| Category: Diabetes | ||||||
| 08/26/2022 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $11.90 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/15/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $22.74 | General |
| Category: DIABETES | ||||||
| 08/11/2022 | PFIZER INC. | MYFEMBREE (Drug) | Education | In-kind items and services | $23.04 | General |
| Category: GENITOURINARY (SEXUAL HEALTH);WOMENS HEALTH | ||||||
| 08/02/2022 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $27.08 | General |
| Category: CARDIOVASCULAR | ||||||
| 06/20/2022 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $9.05 | General |
| Category: Diabetes | ||||||
| 04/12/2022 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $22.69 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 483 | 657 | $280,088 | $65,230 |
| 2022 | 9 | 390 | 468 | $12,362 | $4,751 |
| 2021 | 12 | 791 | 1,074 | $29,233 | $12,305 |
| 2020 | 13 | 725 | 1,107 | $26,722 | $10,839 |
Total Patients
2,389
Total Services
3,306
Medicare Billing
$93,125
Procedure Codes
44
All Medicare Procedures & Services
44 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99305 | Initial nursing facility care with moderate level of medical decision making, per day, if using time, at least 35 minutes | Facility | 2023 | 144 | 160 | $76,160 | $16,750 | 22.0% |
| 99309 | Subsequent nursing facility care with moderate level of medical decision making, per day, if using time, at least 30 minutes | Facility | 2023 | 88 | 149 | $49,915 | $12,272 | 24.6% |
| 99306 | Initial nursing facility care with high level of medical decision making, per day, if using time, at least 45 minutes | Facility | 2023 | 74 | 83 | $50,796 | $11,887 | 23.4% |
| 99309 | Subsequent nursing facility care with moderate level of medical decision making, per day, if using time, at least 30 minutes | Office | 2023 | 65 | 139 | $46,565 | $11,601 | 24.9% |
| 99310 | Subsequent nursing facility care with high level of medical decision making, per day, if using time, at least 45 minutes | Facility | 2023 | 31 | 38 | $18,886 | $4,580 | 24.3% |
| 99310 | Subsequent nursing facility care with high level of medical decision making, per day, if using time, at least 45 minutes | Office | 2023 | 13 | 18 | $8,946 | $2,170 | 24.3% |
| 99497 | Advance care planning, first 30 minutes | Facility | 2023 | 31 | 31 | $10,230 | $1,836 | 17.9% |
| 99306 | Initial nursing facility care with high level of medical decision making, per day, if using time, at least 45 minutes | Office | 2023 | 11 | 12 | $7,344 | $1,717 | 23.4% |
| 99305 | Initial nursing facility care with moderate level of medical decision making, per day, if using time, at least 35 minutes | Office | 2023 | 15 | 16 | $7,616 | $1,701 | 22.3% |
| 99497 | Advance care planning, first 30 minutes | Office | 2023 | 11 | 11 | $3,630 | $717.31 | 19.8% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2022 | 128 | 159 | $2,544 | $1,221 | 48.0% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2022 | 71 | 81 | $1,620 | $846.24 | 52.2% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2022 | 57 | 61 | $2,013 | $807.54 | 40.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 12 | 14 | $2,983 | $623.53 | 20.9% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2022 | 34 | 35 | $1,190 | $580.69 | 48.8% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 32 | 40 | $800.00 | $382.75 | 47.8% |
| 80048 | Blood test, basic group of blood chemicals (calcium, total) | Office | 2022 | 13 | 16 | $208.00 | $133.43 | 64.1% |
| 81003 | Automated urinalysis test | Office | 2022 | 32 | 50 | $800.00 | $111.34 | 13.9% |
| 93005 | Routine electrocardiogram (ecg) using at least 12 leads with tracing | Office | 2022 | 11 | 12 | $204.00 | $44.27 | 21.7% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2021 | 176 | 240 | $4,800 | $2,526 | 52.6% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2021 | 187 | 290 | $4,640 | $2,248 | 48.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 22 | 35 | $7,420 | $2,020 | 27.2% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2021 | 121 | 135 | $3,807 | $1,808 | 47.5% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2021 | 68 | 82 | $2,788 | $1,378 | 49.4% |
| 83036 | Hemoglobin a1c level | Office | 2021 | 65 | 97 | $1,940 | $941.87 | 48.6% |
About Dr. Julie Moran, M.D
Dr. Julie Moran, M.D is a Family Medicine healthcare provider based in Deer Park, Washington. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/22/2005. The National Provider Identifier (NPI) number assigned to this provider is 1558367961.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Julie Moran, M.D has received a total of $3,539 in payments from pharmaceutical and medical device companies, with $66.75 received in 2024. These payments were reported across 171 transactions from 32 companies. The most common payment nature is "Food and Beverage" ($3,396).
As a Medicare-enrolled provider, Moran has provided services to 2,389 Medicare beneficiaries, totaling 3,306 services with total Medicare billing of $93,125. Data is available for 4 years (2020–2023), covering 44 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Deer Park, WA
- Active Since 06/22/2005
- Last Updated 12/18/2018
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1558367961
Products in Payments
- Ozempic (Drug) $275.02
- Victoza (Drug) $239.97
- TRELEGY ELLIPTA (Drug) $166.47
- MOUNJARO (Drug) $134.04
- XARELTO (Drug) $132.09
- ENTRESTO (Drug) $130.16
- VRAYLAR (Drug) $107.46
- PRADAXA (Drug) $106.70
- FARXIGA (Drug) $103.64
- Tresiba (Drug) $100.94
- Aimovig (Biological) $90.76
- MYRBETRIQ (Drug) $77.25
- PREVNAR 13 (Biological) $76.62
- Xultophy 100/3.6 (Drug) $68.89
- EMGALITY (Drug) $67.38
- BOTOX (Biological) $66.75
- Senza (Device) $61.91
- STIOLTO (Drug) $56.91
- STIOLTO RESPIMAT (Drug) $55.60
- ImmunoCAP (Device) $51.00
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Deer Park
Behrouz Farahmandpour, D.o, D.O
Family Medicine — Payments: $30,635
Family Medicine $30,635
Francine Dimaria, D.o, D.O
Family Medicine — Payments: $9,445
Family Medicine $9,445
Dr. Edwardo Yambo, Md, MD
Family Medicine — Payments: $7,067
Family Medicine $7,067
Dr. Basil Griffin, M.d, M.D
Family Medicine — Payments: $5,527
Family Medicine $5,527
Joseph Dic, D.o, D.O
Family Medicine — Payments: $4,468
Family Medicine $4,468
Dr. Marc Lewandoski, Do, DO
Family Medicine — Payments: $4,031
Family Medicine $4,031